Psychopharmacologic effects of some cholinesterase inhibitors in comparison with imipramine.
D000818:Animals; D001060:Aporphines / Q000037:antagonists & inhibitors*; D001812:Blood-Brain Barrier; D002375:Catalepsy / Q000188:drug therapy*; D002746:Chlorpromazine / Q000037:antagonists & inhibitors*; D003214:Conditioning, Classical / Q000187:drug effects*; D004336:Drug Antagonism; D006801:Humans; D007099:Imipramine / Q000494:pharmacology*; D007531:Isoflurophate / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009388:Neostigmine / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology*; D051381:Rats; D013747:Tetrabenazine / Q000037:antagonists & inhibitors*
D001060:Aporphines; D007531:Isoflurophate; D009388:Neostigmine; D010830:Physostigmine; D007099:Imipramine; D002746:Chlorpromazine; D013747:Tetrabenazine